Celltrion Symposium: Expansion of treatment options in RA
Supported by Celltrion
Celltrion healthcare

12:20 – 13:20 Industry Symposium: Expansion of treatment options in RA
Supported by Celltrion

Hall A
Chairperson
12:20 – 12:25 Welcome and Introduction
12:25 – 12:40 The truth of biosimilar against clinicians’ concern
12:40 – 12:55 Future of biosimilar infliximab and global status
Tore K. Kvien, Norway
12:55 – 13:10 Compelling clinical evidence from real world data
13:10 – 13:20 Panel Discussion